Clinical Trial

Transcriptomic Study of Adult Population With Marfan Syndrome

Study acronym: MaRfaNomicA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This project is designed to discover circulating biomarkers for aortic aneurysms in adults affected by Marfan Syndrome (MFS). The first aim is to identify circulating transcripts, protein-coding (mRNA) and not (ncRNAs), which show differential expression between three groups of adult patients affected by MFS, based on: presence or absence of thoracic aortic aneurysms (TAA) and indication of TAA-surgery. This obtained TAA\_MFS\_signature will then be correlated to fundamental biological parameters, like cytokines and chemokines relevant during inflammation and transcriptomic as well as epigenetics changes in aortic aneurysm tissue. Furthermore, the association of TAA\_MFS\_signature to genetic, clinical and instrumental parameters at present used for diagnosis and treatment, will be evaluated.
Trial Details
NCT Number NCT05700175
Lead Sponsor IRCCS Policlinico S. Donato
Conditions Marfan Syndrome, Marfan's Syndrome With Cardiovascular Manifestations
Enrollment 99 participants
Start Date 2021-11-02
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-02